Ironwood Pharmaceuticals
IRWD
IRWD
220 hedge funds and large institutions have $672M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
5.78% less ownership
Funds ownership: 107.87% → 102.09% (-5.8%)
15% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 46
40% less capital invested
Capital invested by funds: $1.12B → $672M (-$445M)
Holders
220
Holding in Top 10
1
Calls
$46.4M
Puts
$50K
Top Buyers
| 1 | +$9.77M | |
| 2 | +$8.42M | |
| 3 | +$3.92M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.24M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.79M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$9.1M | |
| 3 | -$8.61M | |
| 4 |
First Eagle Investment Management
New York
|
-$7.2M |
| 5 |
JPMorgan Chase & Co
New York
|
-$6.37M |